Back to search

PES-EUR-Prosjektetablererstøtte Eureka

SerodISH: Development of a new chemical entity (Ser-100) in the treatment of Isolated Systolic Hypertension

Awarded: NOK 94,000

Funding scheme:

PES-EUR-Prosjektetablererstøtte Eureka